Literature DB >> 24488669

Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach.

Lei Lou, Yuan Wang1, Jinfeng Cui, Xia Yan, Liying Xue, Yuehong Li.   

Abstract

Gastric cardia adenocarcinoma (GCA) is distinct from adenocarcinoma of the distal stomach because of its different etiological factors, tumor characteristics, and biological behavior. However, its pathogenesis is not fully understood. The purpose of this study is to characterize the role of Pim-3, c-Myc, and p-p27 in the tumorigenesis and progression of different sites of gastric adenocarcinoma by determining its pathogenetic significance. The expression of Pim-3, c-Myc, and p-p27 proteins was evaluated by immunohistochemistry in 140 resection specimens of gastric adenocarcinomas (78 GCAs , 62 DGAs and 20 normal gastric tissues). The level of expression of Pim-3, c-Myc, and p-p27 and the co-expression of all three markers (Pim-3+/c-Myc+/p-p27+) in GCA were significantly lower than that in DGA tumors (P < 0.05). Detailed analysis of the immunoreactivity patterns showed that in DGA, Pim-3 immunoreactivity was associated significantly with poor tumor differentiation, advanced tumor stage, and presence of lymph node metastasis. In addition, c-Myc overexpression correlated with tumor stage and lymph node metastasis, and positive p-p27 expression correlated with poor differentiation and tumor stage. The phenotype of Pim-3(+)/c-Myc(+)/p-p27(+) co-expression was closely correlated with tumor stage and lymph node metastasis (P < 0.05). In contrast, GCA only demonstrated a close correlation of Pim-3 overexpression with poor tumor differentiation and tumor stage (P < 0.05). Our results demonstrate the presence of different expression patterns of Pim-3, c-Myc, p-p27, and Pim-3(+)/c-Myc(+)/p-p27(+) and their clinicopathologic significance in GCA and DGA tumors. Our results add support to the notion that distinct molecular mechanisms may be involved in the development and progression of adenocarcinomas from the gastric cardia and distal portion of stomach.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488669     DOI: 10.1007/s13277-014-1664-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  47 in total

1.  Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.

Authors:  M Ohtani; H Isozaki; K Fujii; E Nomura; M Niki; H Mabuchi; K Nishiguchi; M Toyoda; T Ishibashi; N Tanigawa
Journal:  Cancer       Date:  1999-04-15       Impact factor: 6.860

2.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Authors:  M Loda; B Cukor; S W Tam; P Lavin; M Fiorentino; G F Draetta; J M Jessup; M Pagano
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.

Authors:  J Vlach; S Hennecke; K Alevizopoulos; D Conti; B Amati
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

Review 4.  Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.

Authors:  J Rüdiger Siewert; Marcus Feith; Hubert J Stein
Journal:  J Surg Oncol       Date:  2005-06-01       Impact factor: 3.454

Review 5.  Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction.

Authors:  M Pera
Journal:  Recent Results Cancer Res       Date:  2000

6.  Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

Authors:  V Esposito; A Baldi; A De Luca; A M Groger; M Loda; G G Giordano; M Caputi; F Baldi; M Pagano; A Giordano
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

7.  Adenocarcinoma of the esophagus and/or gastric cardia.

Authors:  W C MacDonald; J B MacDonald
Journal:  Cancer       Date:  1987-09-01       Impact factor: 6.860

8.  Pim kinase-dependent inhibition of c-Myc degradation.

Authors:  Y Zhang; Z Wang; X Li; N S Magnuson
Journal:  Oncogene       Date:  2008-04-28       Impact factor: 9.867

9.  [Cardia cancer: attempt at a therapeutically relevant classification].

Authors:  J R Siewert; A H Hölscher; K Becker; W Gössner
Journal:  Chirurg       Date:  1987-01       Impact factor: 0.955

10.  High-throughput retroviral tagging to identify components of specific signaling pathways in cancer.

Authors:  Harald Mikkers; John Allen; Puck Knipscheer; Like Romeijn; Augustinus Hart; Edwin Vink; Anton Berns; Lieke Romeyn
Journal:  Nat Genet       Date:  2002-08-19       Impact factor: 38.330

View more
  9 in total

1.  Expression of Pim-3 in colorectal cancer and its relationship with prognosis.

Authors:  Zhongguo Zhou; Rongxin Zhang; Ruojing Wang; Yaojun Zhang; Li Xu; Jinbin Chen; Jie Zhang; Zhongxi Huang; Minshan Chen; Zhizhong Pan
Journal:  Tumour Biol       Date:  2016-01-14

2.  CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.

Authors:  Jing Wei; Guanzhen Yu; Genbao Shao; Aiqin Sun; Miao Chen; Wannian Yang; Qiong Lin
Journal:  Oncotarget       Date:  2016-05-24

3.  Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells.

Authors:  Qie Guo; Zhong-Guo Sui; Wen Xu; Xiang-Hua Quan; Jia-Lin Sun; Xiao Li; Hong-Yan Ji; Fan-Bo Jing
Journal:  Oncotarget       Date:  2017-08-10

4.  The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma.

Authors:  Jing Wei; Lincui Wang; Jun Zhu; Aiqin Sun; Guanzhen Yu; Miao Chen; Pan Huang; Hanqing Liu; Genbao Shao; Wannian Yang; Qiong Lin
Journal:  Cancer Cell Int       Date:  2019-03-29       Impact factor: 5.722

5.  New prognostic markers revealed by RNA-Seq transcriptome analysis after MYC silencing in a metastatic gastric cancer cell line.

Authors:  Luana de O Lopes; Jersey H Maués; Hygor Ferreira-Fernandes; France K Yoshioka; Severino C Sousa Júnior; Alcemir R Santos; Helem F Ribeiro; Juan A Rey; Paulo C Soares; Rommel R Burbano; Giovanny R Pinto
Journal:  Oncotarget       Date:  2019-10-08

6.  High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms.

Authors:  Ewelina Motylewska; Marcin Braun; Henryk Stępień
Journal:  Endocr Pathol       Date:  2020-09       Impact factor: 3.943

7.  Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients.

Authors:  Rong-Xin Zhang; Zhong-Guo Zhou; Shi-Xun Lu; Zhen-Hai Lu; De-Sen Wan; Zhi-Zhong Pan; Xiao-Jun Wu; Gong Chen
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

8.  Clinical significances of p27 in digestive tract cancers: a comprehensive analysis on immunohistochemistry staining, published literatures, microarray and RNA-seq data.

Authors:  Dan-Dan Xiong; Rong-Quan He; Ai-Hua Lan; Wen-Jie Chen; Yi-Huan Luo; Zhi-Hua Ye; Jie Ma; Gang Chen; Yi-Wu Dang
Journal:  Oncotarget       Date:  2018-01-23

Review 9.  PIM Kinase as an Executional Target in Cancer.

Authors:  Xinning Zhang; Mengqiu Song; Joydeb Kumar Kundu; Mee-Hyun Lee; Zhen-Zhen Liu
Journal:  J Cancer Prev       Date:  2018-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.